查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830356

医疗诊断市场人工智慧（按组件、技术类型、部署模式、应用和最终用户划分）—全球预测，2025-2032

Artificial Intelligence in Medical Diagnostics Market by Component, Technology Type, Deployment Mode, Application, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医疗诊断人工智慧市场将成长至 52.6 亿美元，复合年增长率为 15.40%。

主要市场统计数据
基准年2024年 16.7亿美元
预计2025年 19.1亿美元
预测年份：2032年 52.6亿美元
复合年增长率（%） 15.40%

简明说明演算法进步、临床检验需求和系统互通性如何重新定义现代医疗保健中的诊断途径

人工智慧正在重塑临床医生、实验室专业人员和医疗管理人员的诊断方式，在演算法洞察和临床工作流程之间建立新的介面。近年来，模型架构的改进、更丰富的临床资料集的取得以及影像技术的日益成熟，提升了人工智慧驱动工具在诊断路径中的实用性。因此，为了减少诊断延迟并提高解读的一致性，各机构正优先投资于将预测分析和影像解读融入标准护理流程的整合解决方案。

此外，监管机构和临床协会正在加强对演算法安全性、可解释性和临床检验的指导和监督，开发团队也敦促他们将产品开发与反映临床试验严谨性的证据标准相结合。这些监管变革，加上对电子健康记录和实验室资讯系统互通性的日益重视，迫使供应商采用模组化、基于标准的架构。同时，付款方和医疗服务提供者网路也逐渐认识到人工智慧诊断技术的潜在运作和临床效益，并正在试验报销框架和基于价值的安排。

随着人工智慧在医疗点、诊断影像中心和中心实验室的应用不断扩展，相关人员必须在快速创新与强有力的管治和风险管理之间取得平衡。因此，领导者必须优先考虑资料科学家、临床医生和监管专家之间的跨职能协作，以确保人工智慧工具展现出透明的性能、在不同人群中实现公平的结果，并无缝整合到现有的诊断路径中。

深度学习、多模态临床数据和管治前景如何重塑诊断实践和筹资策略

先进的机器学习技术、更丰富的多模态资料集以及日益增长的临床级效能期望，这些因素的融合正在显着改变医学诊断领域。深度学习和电脑视觉正在提升基于影像的诊断能力，实现放射科、病理科和眼科领域病理的自动检测、分割和表征。同时，自然语言处理和资料探勘方法正在从非结构化的临床记录和实验室报告中提取洞见，以增强诊断背景和决策支援。

组织的优先事项正在从孤立的先导计画转向企业级部署，这需要强大的变更管理和临床效用的验证。这种转变与对可解释性和公平性的日益重视相吻合，演算法开发人员整合了可解释性功能和偏差缓解策略，以满足临床医生和监管机构的要求。同时，部署方法也日趋多样化，组织在云端基础可扩展性和本地控制之间进行权衡，以满足资料驻留、延迟和隐私方面的要求。这一趋势正在促进技术供应商、医疗保健系统和学术中心之间的伙伴关係，共同开发符合临床工作流程和合规性需求的解决方案。

最后，人工智慧与诊断的融合正在创造超越单一检测增强的全新价值提案。结合影像、基因组和纵向临床数据的预测分析，正在协助实现早期风险分层和个人化照护计画。因此，相关人员正在重新评估筹资策略、技术架构和管治框架，以期在管理营运复杂性和道德义务的同时，获得演算法洞察的优势。

评估近期美国关税如何促使诊断解决方案的硬体采购、以软体为中心的调整和供应链弹性策略转变

美国近期宣布的关税调整和贸易措施引入了新的限制和奖励，对人工智慧诊断系统的供应链产生了重大影响。由于关税增加了进口成本并限制了供应商的选择，为高效能推理平台和影像处理工作站提供支援的记忆体和处理器等硬体组件面临成本上升的压力。因此，解决方案架构师和采购主管正在重新考虑其整体拥有成本和筹资策略，寻求替代的供应路线和本地製造以降低风险。

为了因应这项政策转变，一些相关人员正在加速向以软体为中心、云端支援的模式转型，以减少对本地专用伺服器的依赖，同时协商长期采购合约以锁定组件价格。然而，云端策略也存在自身的考量因素，包括资料传输成本、跨境资料管治以及即时影像处理工作流程中潜在的延迟限制。因此，管治团队必须重新调整其风险评估，以适应硬体采购和软体订阅模式之间不断变化的平衡。

此外，这些关税还鼓励对国内能力建设倡议和战略伙伴关係的投资，旨在确保关键部件的弹性供应线。监管和采购团队正在与供应商合作，确保零件来源的透明度，并实施紧急时应对计画，以便在供应中断时维持临床运作。最后，这些关税促使人们广泛重新评估诊断解决方案的设计、采购和部署方式，以支持强调模组化、云端互通性和灵活资金筹措条款的架构，以应对不断变化的贸易动态。

详细的细分洞察揭示了组件、技术、部署模式、临床用途和最终用户设定如何定义差异化的采用路径

细緻的细分框架明确了医疗诊断生态系统中人工智慧的采用路径和产品优先顺序。依组件划分，需求分为硬体、服务和软体。硬体需求专注于高吞吐量记忆体和处理器，以支援即时推理和进阶影像重建；而服务主要涵盖安装和整合工作流程，以确保临床系统得到配置、检验并被护理团队接受。软体产品范围广泛，从辅助解读的诊断软体、增强视觉化和工作流程的影像软体，到用于风险分层的随时间推移资料合成的预测分析软体。

按技术类型划分，解决方案涵盖从针对影像分析最佳化的电脑视觉系统到揭示临床储存库中潜在模式的资料探勘工具。深度学习模型驱动许多高效能成像任务，而机器学习技术和自然语言处理则分别支援非结构化资料的预测建模和解释。云端基础的平台提供可扩展性、持续的模型更新和集中式管治，而本地配置则提供本地化控制、特定工作流程的低延迟以及符合严格的资料驻留要求。

以应用为中心的细分突出了多样化的临床用例。影像和诊断应用涵盖心臟病学、神经病学、妇产科、肿瘤学、眼科和放射学，每个领域都需要客製化的检验资料集和临床医生工作流程。体外诊断应用包括伴随诊断、免疫诊断和分子诊断，这些应用将演算法解读与检测设备和报告系统结合。个人化医疗工作流程依赖预测分析来客製化治疗决策，而远端监控和远端医疗解决方案则利用演算法进行分诊护理和监测病情进展。最后，最终用户细分认识到，学术机构、诊断中心、医院和实验室之间的采用动态差异很大，每个机构都有其独特的采购週期、监管期望和整合挑战。

区域比较分析显示法律规范、数位基础设施和组织优先事项将如何影响全球市场的采用轨迹

区域动态将决定人工智慧在医疗诊断领域的应用速度、监管预期和投资重点。在美洲，医疗系统和私人支付机构正在积极试点和扩展人工智慧解决方案，重点关注互通性、报销协调以及与高通量成像工作流程的整合。学术医疗中心和大型医院网路通常作为早期采用者和参考点，支援临床检验研究和上市后监测活动，为更广泛的部署提供参考。

在欧洲、中东和非洲，监管协调和隐私框架正在推动决策制定，提供者主导资料保护、模型可解释性和跨境资料传输的保障措施。公共部门医疗保健系统和国家采购机制将影响采用的速度，而本地原始设备製造商 (OEM) 和本地整合商之间的伙伴关係通常决定了部署的可行性，尤其是在数位基础设施差异很大的地区。

在亚太地区，快速的数位化、庞大的患者数量以及强大的公私合作正在加速人工智慧诊断工作流程的发展。能力建设计划以及对国内半导体和倡议能力的投资也影响着采购决策，而临床实践的地区多样性使得训练资料集和临床检验通讯协定的在地化变得至关重要。在所有地区，跨境合作、监管一致性和基础设施投资仍然是广泛且公平地部署人工智慧诊断的关键因素。

竞争动态、伙伴关係和证据产生策略如何影响诊断 AI 生态系统中的供应商差异化和采用结果

关键的公司层面动态表明，一个生态系统正在形成：成熟的技术提供者、专业的医疗设备製造商和敏捷的新兴企业都发挥互补作用。市场领导倾向于透过端到端产品实现差异化，这些产品将经过检验的演算法与强大的部署工具、临床医生可用的可解释性以及整合和培训支援服务相结合。同时，专业公司则专注于高价值的利基领域，例如用于肿瘤学的高级影像处理演算法或用于病理学的诊断决策支持，并利用深入的临床伙伴关係关係来加速检验和应用。

在这种竞争格局下，策略活动包括与学术中心合作以确保高品质的训练资料集和临床试验合作者，与云端供应商合作以确保扩充性的基础设施，以及与系统整合商合作以简化在复杂医疗IT环境中的部署。此外，企业也高度重视创建监管文件和上市后证据集，以满足临床相关人员和监管机构的需求。新参与企业专注于透过可解释性、偏差缓解和工作流程人体工学来实现差异化，而现有企业则投资模组化架构和API以保持竞争力。

整体而言，竞争格局青睐那些能够证明临床有效性、提供透明绩效指标并简化从试点到企业部署路径的公司。在临床检验、安全性和无缝互通性方面表现优异的公司将最有可能在复杂的医疗保健生态系统中获得持续的采用。

医疗保健领导者在管理检验、管治和供应链风险的同时，实用化人工智慧主导诊断的可行策略重点

产业领导者应采取协作方式，将技术前景转化为可衡量的临床和营运成果。首先，优先考虑稳健的临床检验途径，包括在多学科团队和代表性的临床环境中进行前瞻性评估。其次，采用模组化系统设计，以促进增量部署，从而允许整合特定的诊断软体或预测模组，而无需彻底改造基础设施。

第三，透过实施来源追踪、模型版本控制和偏差评估通讯协定来加强资料管治，以确保在患者群体中公平地执行资料。同时，评估混合部署架构，以平衡云端基础可扩展性与本地控制，从而应对延迟敏感的工作流程。第四，建立策略供应商关係并制定应急计划，以降低供应链风险，特别是针对记忆体和处理器等关键硬体元件的风险。

最后，投资以临床医生为中心的设计、培训和变革管理，确保AI工具能够增强临床决策，而不是引入工作流程摩擦。透过在实施生命週期的早期协调产品开发、采购和临床营运团队，组织可以加速采用，展现更佳的疗效，并向付款人和医疗系统领导者提出可靠的价值提案。

本研究采用多方法论，结合了初步访谈、同行评审文献、监管指南和技术白皮书，旨在建构对医疗诊断领域人工智慧的全面视角。研究收集了来自临床医生、实验室主任、医疗IT架构师和监管专家的主要定性信息，以了解现实世界的实施挑战和优先事项。技术评估评估了电脑视觉、深度学习、机器学习、资料探勘和自然语言处理等演算法方法，以了解它们的优势、局限性以及对特定临床任务的适用性。

此外，部署模式分析比较了云端基础和本地部署模型在可扩展性、延迟和资料管治的差异。应用层级的洞察从诊断成像、体外诊断、个人化医疗和远端监控场景的案例研究中阐明了工作流程整合和检验要求。最终使用者观点分析了学术机构、诊断中心、医院和实验室，重点关注采购週期、技术准备和采用障碍。最后，供应链和政策分析检视了关税、零件采购和国内製造奖励对硬体可用性和筹资策略的影响。

自始至终，研究结果都具有可复製性和透明度。方法论附录提供了访谈通讯协定、文献综述的纳入标准以及技术评估框架，方便读者解读依证，并根据自身组织情境调整结论。

总之，我们强调证据主导的部署、跨职能协作和弹性架构对于实现诊断 AI 的优势至关重要。

总而言之，人工智慧在医疗诊断领域的整合正从孤立的试点阶段发展到整合的临床工作流程，从而在影像、检测和病患监测提供切实可行的洞察。这项转变的驱动因素包括：模型表现的提升、临床医师对演算法辅助的接受度不断提高，以及对检验和管治的日益重视，以确保病人安全和公平的结果。同时，政策变革和贸易动态正在再形成供应链决策，推动相关人员走向软体优先的架构和多元化的筹资策略。

开发人员必须优先考虑临床有效性和可解释性，医疗保健提供者必须进行严格的评估和临床医生培训，相关人员必须考虑能够实现可证明的临床和营运改进的报销模式。透过使技术设计与监管期望和营运现实一致，组织可以发挥人工智慧的潜力，提高诊断准确性、提升效率，并支援提供更个人化的医疗服务。最终，实现持续影响的途径在于将技术创新与严谨的证据产生和切实可行的部署策略结合。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 用于持续健康监测和早期发现医疗状况的可穿戴人工智慧设备的成长
  • 基于人工智慧的预测分析技术在识别潜在疫情和疾病模式的进展
  • 引入人工智慧决策支援系统，减少临床环境中的诊断错误
  • 实施自然语言处理，从非结构化医疗记录中提取见解
  • 开发即时人工智慧诊断以支援远端医疗和远端患者监护
  • 新兴的联邦学习方法可在 AI 诊断模型训练期间保护病患资料隐私
  • 根据患者特定的诊断数据扩展人工智慧主导的个人化治疗计划
  • 利用深度学习模型进行放射学和病理学的自动影像分析
  • 早期癌症诊断和预后预测的机器学习演算法介绍
  • 整合人工智慧诊断工具，改善疾病检测与分析

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 医疗诊断市场中的人工智慧（按组件）

  • 硬体
    • 记忆
    • 处理器
  • 服务
    • 安装和集成
  • 软体
    • 诊断软体
    • 影像软体
    • 预测分析软体

9. 医疗诊断市场中的人工智慧（依技术类型）

  • 电脑视觉
  • 资料探勘
  • 深度学习
  • 机器学习
  • 自然语言处理

第 10 章医疗诊断市场中的人工智慧（按部署模式）

  • 云端基础
  • 本地部署

第 11 章。医疗诊断市场中的人工智慧（按应用）

  • 诊断影像应用
    • 心臟病学
    • 神经病学
    • 妇产科
    • 肿瘤学
    • 眼科
    • 放射学
  • 体外诊断应用
    • 伴随诊断
    • 免疫检测诊断
    • 分子诊断
  • 个人化医疗
  • 远端监控和远端医疗

第 12 章。医疗诊断市场中的人工智慧（按最终用户）

  • 学术机构
  • 诊断中心
  • 医院
  • 研究所

第十三章 医疗诊断市场中的人工智慧（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章。医疗诊断市场中的人工智慧（按组）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。各国医疗诊断市场中的人工智慧

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • 3M Company
    • AiCure, LLC
    • Aidoc Medical Ltd.
    • Butterfly Network, Inc.
    • Cera Care Limited
    • Cisco Systems, Inc.
    • Corti-AI
    • Digital Diagnostics Inc.
    • Edifecs, Inc.
    • Enlitic, Inc.
    • Epredia by PHC Holdings Corporation
    • Freenome Holdings, Inc.
    • GE HealthCare Technologies, Inc.
    • General Vision, Inc.
    • Google LLC by Alphabet Inc.
    • Hewlett Packard Enterprise Development LP
    • Imagen Technologies, Inc.
    • Intel Corporation
    • International Business Machines Corporation
    • Johnson & Johnson Services, Inc.
    • Kantify
    • Koninklijke Philips NV
    • Medtronic PLC
    • Microsoft Corporation
    • Nano-X Imaging Ltd.
    • NEC Corporation
    • NVIDIA Corporation
    • Persistent Systems Limited
    • Qure.ai Technologies Private limited
    • Siemens Healthineers AG
    • SigTuple Technologies Private Limited
    • Stryker Corporation
    • Tempus Labs, Inc.
    • VUNO Inc.
Product Code: MRR-43492DACC312

The Artificial Intelligence in Medical Diagnostics Market is projected to grow by USD 5.26 billion at a CAGR of 15.40% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.67 billion
Estimated Year [2025] USD 1.91 billion
Forecast Year [2032] USD 5.26 billion
CAGR (%) 15.40%

A concise orientation to how algorithmic advancement, clinical validation demands, and system interoperability are redefining diagnostic pathways in modern healthcare

Artificial intelligence is reshaping how clinicians, laboratory specialists, and healthcare administrators approach diagnostics, creating new intersections between algorithmic insight and clinical workflow. Over recent years, improvements in model architectures, access to richer clinical datasets, and maturation of imaging modalities have collectively raised the practical applicability of AI-driven tools in diagnostic pathways. Consequently, organizations are prioritizing investments in integrated solutions that embed predictive analytics and image interpretation into standard-of-care processes to reduce diagnostic delay and improve consistency of interpretation.

Moreover, regulatory agencies and clinical societies have increased guidance and scrutiny on algorithmic safety, explainability, and clinical validation, prompting development teams to align product development with evidentiary standards that mirror clinical trial rigor. This regulatory evolution, together with a growing emphasis on interoperability with electronic health records and laboratory information systems, is compelling vendors to adopt modular, standards-based architectures. In turn, payers and provider networks are experimenting with reimbursement frameworks and value-based arrangements that recognize the potential operational and clinical benefits of AI-enabled diagnostics.

As adoption expands across point-of-care, imaging centers, and centralized laboratories, stakeholders must balance rapid innovation with robust governance and risk management. Therefore, leaders should prioritize cross-functional collaboration among data scientists, clinicians, and regulatory experts to ensure that AI tools demonstrate transparent performance, equitable outcomes across diverse populations, and seamless integration into existing diagnostic pathways.

How the convergence of deep learning, multimodal clinical data, and governance expectations is reshaping diagnostic practice and procurement strategies

The landscape of medical diagnostics is undergoing transformative shifts driven by the convergence of advanced machine learning techniques, richer multimodal datasets, and heightened expectations for clinical-grade performance. Deep learning and computer vision have elevated the capabilities of image-based diagnostics, enabling automated detection, segmentation, and characterization of pathologies across radiology, pathology, and ophthalmology. At the same time, natural language processing and data-mining approaches are unlocking insights from unstructured clinical notes and laboratory reports, thereby enhancing diagnostic context and decision support.

Institutional priorities are shifting from siloed pilot projects to enterprise-level deployments that require robust change management and demonstrable clinical utility. This movement is accompanied by a growing emphasis on explainability and fairness, with algorithm developers embedding interpretability features and bias mitigation strategies to satisfy clinicians and regulators. Concurrently, deployment approaches are diversifying; organizations increasingly weigh cloud-based scalability against on-premise control to meet data residency, latency, and privacy requirements. These trends are catalyzing partnerships among technology vendors, healthcare systems, and academic centers to co-develop solutions that align with clinical workflows and compliance needs.

Finally, the integration of AI into diagnostics is creating new value propositions beyond single-test augmentation. Predictive analytics that combine imaging, genomic, and longitudinal clinical data are enabling earlier risk stratification and personalized care planning. As a result, stakeholders are re-evaluating procurement strategies, technical architectures, and governance frameworks to capture the benefits of algorithmic insight while managing operational complexity and ethical obligations.

Assessing how recent United States tariff measures are prompting hardware sourcing shifts, software-centric adaptations, and supply chain resilience strategies for diagnostic solutions

Recent tariff changes and trade measures announced by the United States have introduced a new set of constraints and incentives that meaningfully affect supply chains for AI-enabled diagnostic systems. Hardware components such as memory and processors, which underpin high-performance inference platforms and imaging workstations, face upward cost pressure when tariffs increase import costs and constrain supplier choices. As a consequence, solution architects and procurement leaders are rethinking total cost of ownership and sourcing strategies, seeking alternative supply routes or localized manufacturing to mitigate exposure.

In response to these policy shifts, some stakeholders are accelerating the transition toward software-centric and cloud-enabled models that reduce dependency on specialized on-premise servers, while simultaneously negotiating long-term procurement contracts to lock in component pricing. However, cloud strategies introduce their own considerations: data transfer costs, cross-border data governance, and potential latency constraints for real-time imaging workflows. Therefore, governance teams must recalibrate risk assessments to account for a changing balance between hardware acquisition and software subscription models.

Additionally, tariffs have encouraged investment in domestic capacity-building initiatives and strategic partnerships that aim to secure resilient supply lines for critical components. Regulatory and procurement teams are engaging with vendors to secure transparency around component provenance and to implement contingency planning that preserves clinical operations during supply disruptions. Ultimately, tariffs are catalyzing a broader re-evaluation of how diagnostic solutions are designed, procured, and deployed, favoring architectures that emphasize modularity, cloud interoperability, and flexible financing terms to accommodate evolving trade dynamics.

Detailed segmentation insights revealing how components, technologies, deployment modes, clinical applications, and end-user settings define differentiated adoption pathways

A nuanced segmentation framework illuminates distinct adoption pathways and product priorities across the AI in medical diagnostics ecosystem. When examined by component, demand differentiates between hardware, services, and software. Hardware requirements concentrate on high-throughput memory and processors that support real-time inference and advanced image reconstruction, while services primarily encompass installation and integration workstreams that ensure clinical systems are configured, validated, and accepted by care teams. Software offerings span diagnostic software that aids interpretation, imaging software that enhances visualization and workflow, and predictive analysis software that synthesizes longitudinal data for risk stratification.

By technology type, solutions vary from computer vision systems optimized for image analytics to data mining tools that surface latent patterns across clinical repositories. Deep learning models drive many high-performance image tasks, whereas machine learning techniques and natural language processing enable predictive modeling and unstructured data interpretation, respectively. Choice of deployment mode further differentiates offerings: cloud-based platforms offer scalability, continuous model updates, and centralized governance, while on-premise deployments provide localized control, lower latency for certain workflows, and alignment with strict data residency requirements.

Application-centric segmentation highlights divergent clinical use cases. Imaging and diagnostics applications span cardiology, neurology, obstetrics/gynecology, oncology, ophthalmology, and radiology, each demanding tailored validation datasets and clinician workflows. In-vitro diagnostics applications include companion diagnostics, immunoassay diagnostics, and molecular diagnostics, which integrate algorithmic interpretation with laboratory instrumentation and reporting systems. Personalized medicine workflows rely on predictive analysis to tailor therapeutic decisions, and remote monitoring and telehealth solutions leverage algorithms to triage care and monitor disease progression. Finally, end-user segmentation recognizes that adoption dynamics differ substantially across academic institutions, diagnostic centers, hospitals, and research laboratories, with each setting imposing unique procurement cycles, regulatory expectations, and integration challenges.

Comparative regional analysis showing how regulatory frameworks, digital infrastructure, and institutional priorities influence adoption trajectories across global markets

Regional dynamics shape the adoption velocity, regulatory expectations, and investment priorities for AI in medical diagnostics. In the Americas, health systems and private payers are actively piloting and scaling AI solutions, with a strong emphasis on interoperability, reimbursement alignment, and integration into high-throughput imaging workflows. Academic medical centers and large hospital networks often act as early adopters and reference sites, supporting clinical validation studies and post-market surveillance activities that inform broader rollouts.

Across Europe, the Middle East & Africa, regulatory harmonization and privacy frameworks lead decision-making, with providers emphasizing data protection, model explainability, and cross-border data transfer safeguards. Public-sector health systems and national procurement mechanisms influence the pace of adoption, and partnerships between regional OEMs and local integrators frequently determine rollout feasibility, particularly in contexts where digital infrastructure varies widely.

In the Asia-Pacific region, rapid digitization, large patient volumes, and strong public-private collaboration have accelerated development of AI-powered diagnostic workflows. Capacity-building initiatives and investments in domestic semiconductor and cloud capabilities are also influencing procurement decisions, while regional diversity in clinical practice necessitates careful localization of training datasets and clinical validation protocols. Across all regions, cross-border collaborations, regulatory consonance, and infrastructure investments remain key enablers for broad and equitable deployment of AI-enabled diagnostics.

How competitive dynamics, partnerships, and evidence generation strategies are shaping vendor differentiation and adoption outcomes in the diagnostic AI ecosystem

Key company-level dynamics demonstrate an ecosystem in which established technology providers, specialized medical device manufacturers, and agile startups all play complementary roles. Market leaders tend to differentiate through end-to-end offerings that combine validated algorithms with robust deployment tooling, clinician-facing interpretability features, and support services for integration and training. At the same time, specialist companies focus on high-value niches such as advanced imaging algorithms for oncology or diagnostic decision support for pathology, leveraging deep clinical partnerships to accelerate validation and uptake.

Strategic activity across the competitive landscape includes partnerships with academic centers to secure high-quality training datasets and clinical trial collaborators, alliances with cloud vendors to ensure scalable infrastructure, and collaborations with systems integrators to simplify deployment in complex health IT environments. Additionally, there is a pronounced emphasis on creating regulatory dossiers and post-market evidence collections that satisfy both clinical stakeholders and oversight bodies. Emerging entrants are concentrating on differentiating through explainability, bias mitigation, and workflow ergonomics, while incumbents are investing in modular architectures and APIs to maintain relevance.

Overall, the competitive environment favors organizations that can demonstrate clinical impact, provide transparent performance metrics, and streamline the pathway from pilot to enterprise deployment. Companies that excel at clinical validation, security, and seamless interoperability are best positioned to capture sustained adoption within complex healthcare ecosystems.

Actionable strategic priorities for healthcare leaders to operationalize AI-driven diagnostics while managing validation, governance, and supply chain risks

Industry leaders should take a coordinated approach to turn technological promise into measurable clinical and operational outcomes. First, prioritize robust clinical validation pathways that involve multidisciplinary teams and prospective evaluation in representative clinical environments; this approach builds clinician trust and supports regulatory compliance. Secondly, adopt modular system designs that facilitate incremental deployment, allowing organizations to integrate specific diagnostic software or predictive modules without full infrastructure overhaul, thereby reducing disruption and accelerating value realization.

Third, strengthen data governance practices by implementing provenance tracking, model versioning, and bias assessment protocols to ensure equitable performance across patient populations. In parallel, evaluate hybrid deployment architectures that balance cloud-based scalability with on-premise control for latency-sensitive workflows. Fourth, cultivate strategic supplier relationships and contingency plans to mitigate supply chain risk, particularly for critical hardware elements such as memory and processors; such measures should include diversification of suppliers and exploration of long-term procurement arrangements.

Finally, invest in clinician-centric design, training, and change management to ensure that AI tools augment clinical decision-making rather than introduce workflow friction. By aligning product development, procurement, and clinical operational teams early in the adoption lifecycle, organizations can accelerate implementation, demonstrate outcome improvements, and create defensible value propositions for payers and health system leaders.

This research synthesis relies on a multi-method approach that triangulates primary interviews, peer-reviewed literature, regulatory guidance, and technical whitepapers to develop a comprehensive view of AI in medical diagnostics. Primary qualitative inputs were gathered from clinicians, laboratory directors, health IT architects, and regulatory specialists to capture real-world implementation challenges and priorities. Technical assessments evaluated algorithmic approaches across computer vision, deep learning, machine learning, data mining, and natural language processing to understand strengths, limitations, and suitability for distinct clinical tasks.

Additionally, deployment mode analysis compared cloud-based and on-premise models with respect to scalability, latency, and data governance. Application-level insights drew on case studies across imaging and diagnostics, in-vitro diagnostics, personalized medicine, and remote monitoring scenarios to illustrate workflow integration and validation requirements. End-user perspectives were analyzed across academic institutions, diagnostic centers, hospitals, and research laboratories to highlight procurement cycles, technical readiness, and adoption barriers. Finally, supply chain and policy analyses examined the effects of tariff measures, component sourcing, and domestic manufacturing incentives on hardware availability and procurement strategies.

Throughout, findings emphasize reproducibility and transparency: methodology appendices document interview protocols, inclusion criteria for literature review, and technical evaluation frameworks, enabling readers to interpret the evidence base and adapt conclusions to their organizational context.

A concluding synthesis emphasizing the imperative for evidence-driven deployment, cross-functional collaboration, and resilient architectures to realize diagnostic AI benefits

In conclusion, integrating artificial intelligence into medical diagnostics is advancing from isolated pilots toward integrated clinical workflows that deliver actionable insights across imaging, laboratory, and patient-monitoring domains. The transition is driven by improvements in model performance, growing acceptance of algorithmic assistance among clinicians, and increasing emphasis on validation and governance to ensure patient safety and equitable outcomes. At the same time, policy shifts and trade dynamics are reshaping supply chain decisions, nudging stakeholders toward software-first architectures and diversified sourcing strategies.

Moving forward, successful adoption will hinge on multi-stakeholder collaboration: developers must prioritize clinical relevance and explainability, providers must commit to rigorous evaluation and clinician training, and payers must consider reimbursement models that reflect demonstrable clinical and operational improvements. By aligning technical design with regulatory expectations and operational realities, organizations can realize the potential of AI to enhance diagnostic accuracy, increase efficiency, and support more personalized care delivery. Ultimately, the path to sustained impact lies in marrying technological innovation with disciplined evidence generation and pragmatic deployment strategies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growth of wearable AI devices for continuous health monitoring and early detection of medical conditions
  • 5.2. Advancement in AI-based predictive analytics to identify potential outbreaks and disease patterns
  • 5.3. Incorporation of AI-enabled decision support systems to reduce diagnostic errors in clinical practice
  • 5.4. Implementation of natural language processing for extracting insights from unstructured medical records
  • 5.5. Development of real-time AI diagnostics to support telemedicine and remote patient monitoring
  • 5.6. Emergence of federated learning approaches to protect patient data privacy while training AI diagnostic models
  • 5.7. Expansion of AI-driven personalized treatment plans based on patient-specific diagnostic data
  • 5.8. Utilization of deep learning models for automated image analysis in radiology and pathology
  • 5.9. Adoption of machine learning algorithms for early-stage cancer diagnosis and prognosis prediction
  • 5.10. Integration of AI-powered diagnostic tools to enhance accuracy in disease detection and analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Medical Diagnostics Market, by Component

  • 8.1. Hardware
    • 8.1.1. Memory
    • 8.1.2. Processors
  • 8.2. Services
    • 8.2.1. Installation & Integration
  • 8.3. Software
    • 8.3.1. Diagnostic Software
    • 8.3.2. Imaging Software
    • 8.3.3. Predictive Analysis Software

9. Artificial Intelligence in Medical Diagnostics Market, by Technology Type

  • 9.1. Computer Vision
  • 9.2. Data Mining
  • 9.3. Deep Learning
  • 9.4. Machine Learning
  • 9.5. Natural Language Processing

10. Artificial Intelligence in Medical Diagnostics Market, by Deployment Mode

  • 10.1. Cloud-Based
  • 10.2. On-Premise

11. Artificial Intelligence in Medical Diagnostics Market, by Application

  • 11.1. Imaging and Diagnostics Application
    • 11.1.1. Cardiology
    • 11.1.2. Neurology
    • 11.1.3. Obstetrics/Gynecology
    • 11.1.4. Oncology
    • 11.1.5. Ophthalmology
    • 11.1.6. Radiology
  • 11.2. In-Vitro Diagnostics Application
    • 11.2.1. Companion Diagnostics
    • 11.2.2. Immunoassay Diagnostics
    • 11.2.3. Molecular Diagnostics
  • 11.3. Personalized Medicine
  • 11.4. Remote Monitoring & Telehealth

12. Artificial Intelligence in Medical Diagnostics Market, by End-User

  • 12.1. Academic Institutions
  • 12.2. Diagnostic Centers
  • 12.3. Hospitals
  • 12.4. Research Laboratories

13. Artificial Intelligence in Medical Diagnostics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Artificial Intelligence in Medical Diagnostics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Artificial Intelligence in Medical Diagnostics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. 3M Company
    • 16.3.2. AiCure, LLC
    • 16.3.3. Aidoc Medical Ltd.
    • 16.3.4. Butterfly Network, Inc.
    • 16.3.5. Cera Care Limited
    • 16.3.6. Cisco Systems, Inc.
    • 16.3.7. Corti - AI
    • 16.3.8. Digital Diagnostics Inc.
    • 16.3.9. Edifecs, Inc.
    • 16.3.10. Enlitic, Inc.
    • 16.3.11. Epredia by PHC Holdings Corporation
    • 16.3.12. Freenome Holdings, Inc.
    • 16.3.13. GE HealthCare Technologies, Inc.
    • 16.3.14. General Vision, Inc.
    • 16.3.15. Google LLC by Alphabet Inc.
    • 16.3.16. Hewlett Packard Enterprise Development LP
    • 16.3.17. Imagen Technologies, Inc.
    • 16.3.18. Intel Corporation
    • 16.3.19. International Business Machines Corporation
    • 16.3.20. Johnson & Johnson Services, Inc.
    • 16.3.21. Kantify
    • 16.3.22. Koninklijke Philips N.V.
    • 16.3.23. Medtronic PLC
    • 16.3.24. Microsoft Corporation
    • 16.3.25. Nano-X Imaging Ltd.
    • 16.3.26. NEC Corporation
    • 16.3.27. NVIDIA Corporation
    • 16.3.28. Persistent Systems Limited
    • 16.3.29. Qure.ai Technologies Private limited
    • 16.3.30. Siemens Healthineers AG
    • 16.3.31. SigTuple Technologies Private Limited
    • 16.3.32. Stryker Corporation
    • 16.3.33. Tempus Labs, Inc.
    • 16.3.34. VUNO Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MEMORY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MEMORY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MEMORY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MEMORY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MEMORY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MEMORY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PROCESSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PROCESSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PROCESSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PROCESSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PROCESSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PROCESSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPUTER VISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DATA MINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DATA MINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DATA MINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DATA MINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DATA MINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DATA MINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RADIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RADIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IMAGING AND DIAGNOSTICS APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET SIZE, BY COMP